Find a Tender
planning
Official procurement procedure
NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Pharmaceutical products
UK
Published value
£29,042,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for Transition products (Nilotinib and Ticagrelor)". Published status: planning. Published value: £29,042,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | planning No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £29,042,000 |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statusplanning | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published9 Apr 2025, 12:44 BST | Last source update9 Apr 2025, 12:44 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-04ff91 | ||
What is being bought
Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025 Offer reference number: CM/TNS/24/5721 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5721/01 - Nilotinib and Ticagrelor Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months) Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
What changed
From the official release history
- Published value updated to £29,042,000
9 Apr 2025, 12:44 BST - Status changed to planning
9 Apr 2025, 12:44 BST - Official notice release published
9 Apr 2025, 12:44 BST - Buyer information updated
9 Apr 2025, 12:44 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedplanningPublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Pipeline notice
9 Apr 2025, 12:44 BST - Procedure published
9 Apr 2025, 12:44 BST - engagement
25 Apr 2025, 23:59 BST · scheduledNHS England is pleased to invite suppliers to contact us in relation to the upcoming tender for NHS National Framework for Transition products commencing 1st September 2025 (Ticagrelor and Nilotinib ) Please contact katie.noonan@nhs.net for further information and/or to register your interest.
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYDocuments (1)
Official links; attachments are not copied
- 9 Apr 2025, 12:44 BST
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleNot published |